The Effects of Butyrate Enemas on Visceral Perception
NCT00726817 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2017-02-24
Summary
During this double blind, placebo controlled, randomised cross over study, healthy volunteers received an enema once daily for one week containing either placebo (saline), 50mM butyrate or 100mM of butyrate. Before and directly after each test period a barostat protocol was performed to measure parameters for visceral perception.
Conditions
- Visceral (Hyper)Sensitivity
Interventions
- DRUG
-
Butyrate
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
Robert-Jan Brummer, Prof · Maastricht University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-12-31
- Primary Completion
- 2008-02-29
Countries
- Netherlands
Study Locations
More Related Trials
-
The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics
NCT06390787 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Topical Capsaicin for Cyclical Vomiting
NCT03223350 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805 ·Status: COMPLETED ·Phase: PHASE2
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
NCT00946387 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Itopride on Gastric Motor and Sensory Functions in Healthy Volunteers
NCT00370110 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran
NCT03973047 ·Status: COMPLETED ·Phase: PHASE1
-
Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
NCT03470181 ·Status: COMPLETED
-
Effect of Methylnaltrexone on GI Transit in Healthy Volunteers
NCT01055704 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort
NCT02242292 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide
NCT04682860 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
NCT01934192 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways
NCT02633579 ·Status: COMPLETED ·Phase: NA
-
A Trial to Evaluate the Efficacy and Safety of Methoxyethyl Etomidate Hydrochloride in Gastroscopy/Colonoscopy
NCT06682546 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting
NCT00418678 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients
NCT03560583 ·Status: RECRUITING ·Phase: NA
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Prokinetic Effects of Erythromycin in Emergency Patients With a Full Stomach
NCT02296866 ·Status: COMPLETED
-
Effects of Oxybutynin Topical Gel on Gastric Emptying
NCT00926926 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Metoclopramide in Small Bowel Capsule Endoscopy
NCT01630109 ·Status: COMPLETED ·Phase: PHASE4
-
Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS
NCT03932578 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults
NCT01347814 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
NCT00733551 ·Status: COMPLETED ·Phase: PHASE1
-
Uncomplicated Nausea and Vomiting in the Emergency Department
NCT00778011 ·Status: COMPLETED ·Phase: PHASE4
-
Prokinetic Drugs and Enteral Nutrition
NCT00916591 ·Status: UNKNOWN